nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—ADRB1—Endothelin Pathways—ADCY10—nephrolithiasis	0.0504	0.196	CbGpPWpGaD
Esmolol—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0472	0.0635	CcSEcCtD
Esmolol—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.0351	0.0472	CcSEcCtD
Esmolol—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0327	0.0439	CcSEcCtD
Esmolol—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0322	0.0433	CcSEcCtD
Esmolol—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0288	0.0387	CcSEcCtD
Esmolol—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0221	0.0297	CcSEcCtD
Esmolol—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0212	0.0285	CcSEcCtD
Esmolol—ADRB1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0209	0.0815	CbGpPWpGaD
Esmolol—ADRB2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0205	0.0798	CbGpPWpGaD
Esmolol—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0199	0.0268	CcSEcCtD
Esmolol—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0198	0.0266	CcSEcCtD
Esmolol—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0198	0.0266	CcSEcCtD
Esmolol—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0185	0.0248	CcSEcCtD
Esmolol—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0182	0.0245	CcSEcCtD
Esmolol—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.018	0.0242	CcSEcCtD
Esmolol—ADRB1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0176	0.0685	CbGpPWpGaD
Esmolol—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0175	0.0235	CcSEcCtD
Esmolol—ADRB2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0172	0.0671	CbGpPWpGaD
Esmolol—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0168	0.0227	CcSEcCtD
Esmolol—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0158	0.0212	CcSEcCtD
Esmolol—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.0155	0.0208	CcSEcCtD
Esmolol—Agitation—Hydrochlorothiazide—nephrolithiasis	0.0145	0.0195	CcSEcCtD
Esmolol—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0194	CcSEcCtD
Esmolol—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0142	0.0191	CcSEcCtD
Esmolol—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0139	0.0187	CcSEcCtD
Esmolol—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0181	CcSEcCtD
Esmolol—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.0134	0.018	CcSEcCtD
Esmolol—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.0132	0.0177	CcSEcCtD
Esmolol—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.013	0.0175	CcSEcCtD
Esmolol—Oedema—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0173	CcSEcCtD
Esmolol—ADRB1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0128	0.05	CbGpPWpGaD
Esmolol—Shock—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0171	CcSEcCtD
Esmolol—ADRB2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0125	0.0489	CbGpPWpGaD
Esmolol—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0168	CcSEcCtD
Esmolol—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0165	CcSEcCtD
Esmolol—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.012	0.0162	CcSEcCtD
Esmolol—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0156	CcSEcCtD
Esmolol—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0155	CcSEcCtD
Esmolol—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0154	CcSEcCtD
Esmolol—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0153	CcSEcCtD
Esmolol—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0151	CcSEcCtD
Esmolol—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0149	CcSEcCtD
Esmolol—Pain—Hydrochlorothiazide—nephrolithiasis	0.011	0.0148	CcSEcCtD
Esmolol—Constipation—Hydrochlorothiazide—nephrolithiasis	0.011	0.0148	CcSEcCtD
Esmolol—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0143	CcSEcCtD
Esmolol—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0138	CcSEcCtD
Esmolol—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0137	CcSEcCtD
Esmolol—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00925	0.0124	CcSEcCtD
Esmolol—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00912	0.0123	CcSEcCtD
Esmolol—ADRB2—GPCRs, Other—CHRM3—nephrolithiasis	0.00909	0.0354	CbGpPWpGaD
Esmolol—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00852	0.0115	CcSEcCtD
Esmolol—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.0082	0.011	CcSEcCtD
Esmolol—Headache—Hydrochlorothiazide—nephrolithiasis	0.00808	0.0109	CcSEcCtD
Esmolol—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00766	0.0103	CcSEcCtD
Esmolol—ADRB1—G alpha (s) signalling events—PTH—nephrolithiasis	0.00663	0.0259	CbGpPWpGaD
Esmolol—ADRB2—G alpha (s) signalling events—PTH—nephrolithiasis	0.00649	0.0253	CbGpPWpGaD
Esmolol—ADRB1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00626	0.0244	CbGpPWpGaD
Esmolol—ADRB2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00613	0.0239	CbGpPWpGaD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00404	0.0157	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00395	0.0154	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00346	0.0135	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00338	0.0132	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00305	0.0119	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00298	0.0116	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—RGS14—nephrolithiasis	0.00277	0.0108	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—RGS14—nephrolithiasis	0.00271	0.0106	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00263	0.0103	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00258	0.01	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—PTH—nephrolithiasis	0.00241	0.00939	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—PTH—nephrolithiasis	0.00236	0.00919	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00206	0.00803	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—DGKH—nephrolithiasis	0.00201	0.00785	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ADCY10—nephrolithiasis	0.00192	0.0075	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ADCY10—nephrolithiasis	0.00188	0.00733	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—DGKH—nephrolithiasis	0.00187	0.00729	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—DGKH—nephrolithiasis	0.00183	0.00713	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RGS14—nephrolithiasis	0.00163	0.00637	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RGS14—nephrolithiasis	0.0016	0.00623	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00149	0.0058	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00146	0.00568	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PTH—nephrolithiasis	0.00136	0.00531	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00135	0.00527	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PTH—nephrolithiasis	0.00133	0.00519	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CHRM3—nephrolithiasis	0.00132	0.00515	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PTH—nephrolithiasis	0.00124	0.00482	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PTH—nephrolithiasis	0.00121	0.00471	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.0011	0.00431	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—DGKH—nephrolithiasis	0.0011	0.00431	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00108	0.00421	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—DGKH—nephrolithiasis	0.00108	0.00421	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CHRM3—nephrolithiasis	0.000798	0.00311	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CHRM3—nephrolithiasis	0.000781	0.00304	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PTH—nephrolithiasis	0.00073	0.00285	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PTH—nephrolithiasis	0.000714	0.00278	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SPP1—nephrolithiasis	0.000367	0.00143	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SPP1—nephrolithiasis	0.000359	0.0014	CbGpPWpGaD
